期刊文献+

PATL2复合杂合变异致卵母细胞成熟障碍

Compound heterozygous variation of PATL2 causes oocyte maturation defect
下载PDF
导出
摘要 目的探讨1例原发不孕伴卵母细胞成熟障碍患者的遗传学病因。方法对患者DNA进行全外显子组测序(WES),对WES检测到的阳性位点进行Sanger测序验证,并对该位点进行生物学信息分析。结果WES检测到患者PATL2第14和13外显子c.1374A>G(p.Ile458Met)及c.1289_1291delTCC(p.Leu430del)的复合杂合变异,母亲携带c.1289_1291delTCC(p.Leu430del)杂合变异,父亲携带c.1374A>G(p.Ile458Met)的杂合变异。结论患者PATL2复合杂合变异可能是其卵母细胞成熟障碍而不孕的遗传学病因。 Objective To investigate the genetic etiology of a patient with primary infertility and oocyte maturation defect.Methods Whole exome sequencing(WES)was carried out on patient's DNA to detect potential pathologic variants.The positive sites detected by WES were verified by Sanger sequencing,and the bioinformatics analysis of the mutation was analyzed.Results The patient was found to harbor compound heterozygous variants of the PATL2 in exon 14 and 13 c.1374A>G(p.Ile458Met)and c.1289_1291delTCC(p.Leu430del),which were respectively inherited from her father and mother.Conclusions The compound heterozygous variation of PATL2 may be the genetic mechanism to explain infertility resulted from the disturbance of oocyte maturation.
作者 霍明珠 张轶乐 徐家伟 史昊 刘益栋 牛文彬 HUO Ming-zhu;ZHANG Yi-le;XU Jia-wei;SHI Hao;LIU Yi-dong;NIU Wen-bin(Henan Key Laboratory of Reproduction and Genetics, Center for Reproductive Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China)
出处 《基础医学与临床》 2022年第1期51-55,共5页 Basic and Clinical Medicine
基金 国家自然科学基金(81701443,31970799) 中华医学会临床医学科研专项资金生殖医学青年医师研究与发展项目(17020250694)。
关键词 PATL2基因 卵母细胞成熟障碍 PATL2 gene oocyte maturation defect
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部